Source: NPR
Nobody is eager to be stuck by a needle twice, so naturally many would view a COVID-19 vaccine that provides disease protection after a single injection as a good thing.
Two new studies released today suggest that might be possible.
Both studies involved rhesus macaque monkeys. In one study, researchers from Beth Israel Deaconess Medical Center and pharmaceutical company Janssen injected either with a vaccine candidate or an inert placebo. Six weeks after they were vaccinated, the researchers exposed the animals to the coronavirus, both by putting it in their noses and down their throats.
All 20 of the animals receiving the inert, placebo injection showed signs of infection in both their lungs and noses after being exposed to the virus. But one of the vaccine candidates seemed quite effective in preventing infection. In the six animals vaccinated with this particular candidate, none had signs of infection in their lungs, and only one had a sign of infection in the nose.
This is the candidate Janssen’s parent company, Johnson & Johnson has decided to start testing in humans. Initial trials started this week.
The best of the Muslim Times’ collection for war against Covid 19:
In this day and age, understanding bacteria and viruses and developing vaccines are national security issues. In my view sizable part of every country’s defense budget should be spent in these pursuits rather than making tanks and other weapons.
For the latest news about drugs and vaccines’ trials please go to: Pharmaceutical-Technology
For the latest health news from BBC, Please click here
Novavax starting human trial of its vaccine in Australia
Kaiser Permanente launches first coronavirus vaccine trial
Corona Fear’s Cure: Chanting from the Bible and the Quran
Can You Chant from the Bible or the Quran to Bliss and Happiness?
Japanese flu drug ‘clearly effective’ in treating coronavirus, says China
Synthetic antibodies might offer a quick coronavirus treatment
The Four Possible Timelines for Life Returning to Normal
The Muslim Times Recommending Universal BCG Vaccination to Fight the Pandemic
Coronavirus: TB Vaccination Trial Started in Melbourne, Australia
The Muslim Times has the best collections in the war against Covid 19 as we are collecting from all the established sources
All of humanity are intimate neighbors: Coronavirus proves it once again
Praise be to God for the Miracle of Our Immune System
USA: 15-minute coronavirus test is here
Does the Ordinary Soap Kill Coronavirus?
Here’s a list of disinfectants you can use against coronavirus
For the number of cases and epidemiology in each country go to: WorldOMeters
DAILY NEW CASES AND DEATHS IN US, CDC SITE
Categories: The Muslim Times, Vaccine
J&J vaccine protected monkeys with single dose, new study finds
Johnson & Johnson on Thursday released new details of a study that showed its best-performing vaccine candidate provided monkeys with strong protection from the virus with just one dose, Reuters reported. Many other vaccines in development currently require two doses.
The positive results prompted the U.S.-based pharmaceutical company to start human trials for the drug on Thursday, according to Reuters.
“This gives us confidence that we can test a single-shot vaccine in this epidemic and learn whether it has a protective effect in humans,” Dr. Paul Stoffels, J&J’s chief scientific officer, told Reuters.
Earlier today, Johnson & Johnson announced a deal with the U.S. government to supply 100 million doses of its experimental coronavirus vaccine Ad26.COV2.S for around $1 billion.
https://www.fool.com/investing/2020/08/05/why-moderna-stock-is-slipping-today.aspx?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article&yptr=yahoo